Skip to main content

Goldshleger Ilya's Form 4 filing

RxSight, Inc.RXST · filed Nov 8, 2024

Accession no.
0000950170-24-124035
Filed
Nov 8, 2024
Trade date
Nov 7, 2024
Filing delay
1 day
Rule 10b5-1 plan
Checked

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $170.5K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Goldshleger IlyaCIK 0001874147Officer (See remarks)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 7, 2024Common StockMOption exerciseAcquired+3,100$15.08+$46,74845,346Direct
Nov 7, 2024Common StockSSaleDisposed−2,900$54.96F2−$159,38442,446Direct
Nov 7, 2024Common StockSSaleDisposed−200$55.53−$11,10642,246Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Nov 7, 2024Common StockMOption exerciseDisposed−3,100$0.00$059,387Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Represents the weighted average share price of an aggregate total of 2,900 shares sold in the price range of $54.41 to $55.26 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

Remarks

Co-President and Chief Operating Officer

Read the full filing on SEC EDGAR (opens in a new tab)